Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 2
1956 1
1959 1
1963 1
1969 1
1970 1
1971 3
1972 2
1973 2
1974 2
1975 7
1976 4
1977 5
1978 5
1979 7
1980 2
1981 4
1982 5
1983 2
1984 4
1985 6
1986 1
1987 3
1988 6
1989 2
1990 7
1991 11
1992 7
1993 8
1994 7
1995 4
1996 7
1997 4
1998 7
1999 12
2000 11
2001 11
2002 10
2003 15
2004 10
2005 10
2006 22
2007 12
2008 17
2009 15
2010 17
2011 15
2012 18
2013 22
2014 23
2015 26
2016 25
2017 21
2018 21
2019 31
2020 32
2021 42
2022 37
2023 42
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

614 results

Results by year

Filters applied: . Clear all
Page 1
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial.
Paz-Ares L, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Sakai H, Lingua A, Salman P, Souquet PJ, De Marchi P, Martin C, Pérol M, Scherpereel A, Lu S, John T, Carbone DP, Meadows-Shropshire S, Agrawal S, Oukessou A, Yan J, Reck M. Paz-Ares L, et al. Among authors: menezes j. Lancet Oncol. 2021 Feb;22(2):198-211. doi: 10.1016/S1470-2045(20)30641-0. Epub 2021 Jan 18. Lancet Oncol. 2021. PMID: 33476593 Clinical Trial.
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, Dalle S, Arance A, Grob JJ, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV; RELATIVITY-047 Investigators. Tawbi HA, et al. Among authors: de menezes jj. N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970. N Engl J Med. 2022. PMID: 34986285 Free PMC article. Clinical Trial.
Neuronal subtype specification in the cerebral cortex.
Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD. Molyneaux BJ, et al. Among authors: menezes jr. Nat Rev Neurosci. 2007 Jun;8(6):427-37. doi: 10.1038/nrn2151. Nat Rev Neurosci. 2007. PMID: 17514196 Review.
Passive transfer of fibromyalgia symptoms from patients to mice.
Goebel A, Krock E, Gentry C, Israel MR, Jurczak A, Urbina CM, Sandor K, Vastani N, Maurer M, Cuhadar U, Sensi S, Nomura Y, Menezes J, Baharpoor A, Brieskorn L, Sandström A, Tour J, Kadetoff D, Haglund L, Kosek E, Bevan S, Svensson CI, Andersson DA. Goebel A, et al. Among authors: menezes j. J Clin Invest. 2021 Jul 1;131(13):e144201. doi: 10.1172/JCI144201. J Clin Invest. 2021. PMID: 34196305 Free PMC article.
First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update.
Reck M, Ciuleanu TE, Cobo M, Schenker M, Zurawski B, Menezes J, Richardet E, Bennouna J, Felip E, Juan-Vidal O, Alexandru A, Sakai H, Lingua A, Reyes F, Souquet PJ, De Marchi P, Martin C, Pérol M, Scherpereel A, Lu S, Paz-Ares L, Carbone DP, Memaj A, Marimuthu S, Zhang X, Tran P, John T. Reck M, et al. Among authors: menezes j. ESMO Open. 2021 Oct;6(5):100273. doi: 10.1016/j.esmoop.2021.100273. Epub 2021 Oct 1. ESMO Open. 2021. PMID: 34607285 Free PMC article. Clinical Trial.
Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms.
Krock E, Morado-Urbina CE, Menezes J, Hunt MA, Sandström A, Kadetoff D, Tour J, Verma V, Kultima K, Haglund L, Meloto CB, Diatchenko L, Kosek E, Svensson CI. Krock E, et al. Among authors: menezes j. Pain. 2023 Aug 1;164(8):1828-1840. doi: 10.1097/j.pain.0000000000002881. Epub 2023 Mar 22. Pain. 2023. PMID: 36943275 Free PMC article.
Not endangered, but evolving.
Menezes J. Menezes J. Br J Community Nurs. 2015 Aug;20(8):369. doi: 10.12968/bjcn.2015.20.8.369. Br J Community Nurs. 2015. PMID: 26252231 No abstract available.
Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial.
Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O, Menezes J, Reinmuth N, Richardet E, Cheng Y, Mizutani H, Felip E, Zurawski B, Alexandru A, Paz-Ares L, Lu S, John T, Zhang X, Mahmood J, Hu N, De T, Santi I, Penrod JR, Yuan Y, Lee A, Reck M. Carbone DP, et al. Among authors: menezes j. J Immunother Cancer. 2024 Feb 12;12(2):e008189. doi: 10.1136/jitc-2023-008189. J Immunother Cancer. 2024. PMID: 38346853 Free PMC article. Clinical Trial.
Editorial: Immunology and immunopathogenesis of human leishmaniasis.
de Menezes JPB, Brodskyn C, Gonçalves R, Bacellar O. de Menezes JPB, et al. Front Cell Infect Microbiol. 2022 Oct 14;12:1055221. doi: 10.3389/fcimb.2022.1055221. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36310861 Free PMC article. No abstract available.
Lymphoedema care: continually evolving.
Menezes J. Menezes J. Br J Community Nurs. 2016 Apr;Suppl:S5. doi: 10.12968/bjcn.2016.21.Sup4.S5. Br J Community Nurs. 2016. PMID: 27046431 No abstract available.
614 results